logo_top.gif (1243 bytes)
top_search.gif (1405 bytes)
About Alteon
Investor Relations
R&D Pipeline
Clinical Programs
Contact Alteon
Directions to Alteon
Career Opportunities
Links
logo_bottom2_dis.gif (1516 bytes)
top_1.gif (426 bytes) Welcome to Alteon
Alteon Completes Acquisition of HaptoGuard, Inc.
Now With Two Drugs in Development for the Cardiovascular Complications of Diabetes
Alteon Pharmaceuticals

Any statements contained in this web site that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, those relating to technology and product development, regulatory approval processes, intellectual property rights and litigation, competitive products, ability to obtain financing, and other risks identified in Alteon's filings with the Securities and Exchange Commission. The information contained in each section of the website is accurate as of the date indicated. Actual results, events or performances may differ materially. Alteon undertakes no obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstance after the date hereof or to reflect the occurrence of unanticipated events.